Starpharma Holdings LimitedASX: SPL

Starpharma to commence DEP cabazitaxel phase 1/2 trial

Jan 31, 2018 at 5:15 AM UTC · Issued by Starpharma Holdings Limited

Starpharma Holdings Ltd has released a press release.

View Attachment